You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):“小兒荊杏止咳顆粒”國產藥品註冊申請處於“審批完畢-待制證”狀態
格隆匯 12-18 16:30

格隆匯12月18日丨方盛製藥(603998.SH)公佈,近日,經查詢國家藥品監督管理局網站獲悉:公司向國家藥監局提交的“小兒荊杏止咳顆粒”國產藥品註冊申請處於“審批完-待制證”狀態。

待公司取得國家藥監局簽發的正式文件後,公司將按照《上市公司行業信息披露指引第七號——醫藥製造》的有關規定及時披露所涉及的藥品信息、研發投入、市場狀況等有關情況。

“審批完畢-待制證”表示國家藥監局已經審批完畢,其政事項受理服務和投訴舉報中心正在製作批件。由於國家藥監局官網無法查詢到上述藥品的批准文號與具體通知內容,因此,公司尚不知曉最終審批結果是否通過,敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account